At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Learn more about whether Bausch + Lomb Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Bausch + Lomb Corporation or TransMedics Group, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.

The global veterinary eye care market size is estimated to grow by USD 1.05 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.62% during the forecast ...

Bausch + Lomb announced today that, after engagement with potential buyers, it has no immediate plan to sell. At the end of 2024, the company issued a statement outlining its plans for a potential ...

The Global Ophthalmic Viscosurgical Devices market was valued at $705.21 million in 2024 and is projected to grow to $1.65 billion by 2034 , with a CAGR of 8.9% during the forecast period, 2024-2034.

VAUGHAN, Ontario - Bausch + Lomb Corporation (NYSE/TSX: BLCO), a prominent eye health company with a market capitalization of $6.25 billion, has announced the conclusion of its search for a ...

Alcon is downgraded to a hold from my buy rating in fall 2023, after it has gone up +18% since then and now appears ...

Iantrek has reached an exciting milestone as we transition from development of our bio-interventional technologies to ...